Approach to patients with hypertriglyceridemia

Elsevier

Available online 11 April 2022, 101659

Best Practice & Research Clinical Endocrinology & MetabolismAbstract

Elevated triglyceride levels increase the risk of arteriosclerotic cardiovascular disease (ASCVD) and severely elevated triglyceride levels also increase the risk of triglyceride-induced pancreatitis. Although substantially reducing triglyceride levels will prevent pancreatitis, whether lowering triglycerides per se will reduce CVD risk is unclear. In this review, we outline several principles that will help in deciding who and how to treat patients with elevated triglyceride levels in order to prevent both ASCVD and pancreatitis. Using these principles will help in making decisions regarding the treatment of elevated triglyceride levels.

Keywords

Chylomicrons

very low-density lipoproteins

atherosclerotic cardiovascular disease

pancreatitis

statins

omega-3 fatty acids

fibrates

View full text

© 2022 Elsevier Ltd. All rights reserved.

留言 (0)

沒有登入
gif